Elie TraerM.D., Ph.D.

  • Associate Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine

Expertise

  • Cancer

Special focus on

  • Acute Myeloid Leukemia
  • Leukemia
  • Medical Oncology and Hematology

I see patients at

Biography

Dr. Traer completed a fellowship in hematology/oncology from Oregon Health & Science University. He received his M.D./Ph.D. from the University of Texas Southwestern Medical School and completed a residency in internal medicine at Oregon Health & Science University.

In addition to practicing general hematology at OHSU Knight Cancer Institute, Dr. Traer is involved in clinical trials evaluating targeted therapy with kinase inhibitors in leukemia patients. He is performing research with Brian Druker, M.D. to investigate how the bone marrow microenvironment provides sanctuary to leukemia cells by providing critical survival signals, which eventually leads to disease resistance and relapse. He is working to develop new therapies that more effectively target cancer cells within the microenvironment and improve upon existing therapy.

Education

  • Ph.D., 2006, University of Texas Southwestern Medical School
  • M.D., 2006, University of Texas Southwestern Medical School
  • Residency:

    • Internal medicine, Oregon Health & Science University, Portland, Ore.
  • Fellowship:

    • Hematology/oncology, Oregon Health & Science University, Portland, Ore.
  • Certifications:

    • American Board of Internal Medicine

Languages

  • English

Patient ratings

4.9 out of 5 (145 Ratings, 59 Comments)

The patient ratings score is an average of all responses to the question "How likely would you be to recommend this provider to your family and friends (on a scale of 0 to 10)" on our nationally-recognized NRC patient surveys.

  1. {{ item.comments[0]['comment'] }}